查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1438230

2030 年成藥市場預測：按產品、劑型、給藥途徑、分銷管道、最終用戶和地區進行的全球分析

Over the Counter Market Forecasts to 2030 - Global Analysis By Product, Dosage Form, Route of Administration, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球成藥市場規模為 1,733.4 億美元，預計到 2030 年將達到 2,783.4 億美元，預測期內年複合成長率為 7.0%。

成藥(OTC) 是指無需醫療保健專業人員處方箋即可購買的藥物。這些藥物為消費者提供了便捷的解決方案，在解決感冒、身體疼痛、過敏和流感、胃灼熱、痤瘡等輕微健康問題方面發揮重要作用。成藥的例子包括對乙醯胺酚、阿斯匹靈、制酸劑、減充血劑、抗組織胺藥物和瀉藥。這些藥物由許多國家的監管機構選擇，以確保它們含有無需醫療監督即可安全有效服用的化學物質。

美國國立衛生研究院報告稱，93%的美國成年人更成藥。用成藥治療輕微疾病。

自我治療需求不斷成長

隨著越來越多的人尋求無需處方箋即可輕鬆獲得的治療方法，自我治療變得越來越流行。這些藥物現在可以在藥局、超級市場、便利商店以及最近的線上平台上買到。這種可用性使消費者可以輕鬆購買治療小病和日常健康問題的藥物。成藥的另一個優點是它們比處方箋藥便宜。對負擔能力和可近性的關注鼓勵消費者將事情掌握在自己手中，從而促進了成藥市場的整體成長。

安全問題

無需處方箋即可獲得的成藥存在因誤用、濫用和消費者自行服用而產生副作用的風險。對於無法獲得專業醫療指引的消費者來說，劑量不正確、藥物交互作用以及在需要專業介入的情況下依賴非處方藥的可能性會增加。這導致監管機構加強審查，以確保消費者安全。如果出現副作用或安全問題，可能會發生產品召回或監管，這可能會影響市場動態。

世界老化

隨著世界人口老化，與老齡化相關的健康問題和慢性病的盛行率也增加。成藥滿足了老年人日益成長的自我治療需求，為常見疾病提供了方便且經濟高效的解決方案。此外，老齡化往往伴隨著各種健康問題，包括關節疼痛、關節炎、心血管問題和消化器官系統問題。成藥可以為這些常見疾病提供便捷的解決方案，無需處方箋。非處方藥產品，包括維生素、補充品和健康專用藥物，符合維持整體健康和預防老齡化相關問題的趨勢。

與學名藥的競爭

學名藥的推出通常比品牌成藥便宜，這加劇了市場競爭並使知名公司面臨壓力。符合監管標準的學名藥選擇可能會降低報酬率並減少品牌成藥的市場佔有率。此外，隨著學名藥的出現，品牌非成藥可能會失去排他性，這可能導致市場排他性下降並影響品牌藥的銷售和收益。

COVID-19 的影響

疫情期間，由於健康意識增強、預防措施增加以及自我護理產品需求增加，非處方藥銷售量激增。消費者尋求常見病症的治療方法，推動了免疫增強劑、止咳藥和感冒藥以及衛生用品的銷售。然而，供應鏈中斷、消費者支出模式變化以及經濟不確定性也帶來了挑戰。這次疫情凸顯了非處方藥產業適應性和創新的重要性，並塑造了消費行為和市場動態的新趨勢。

預計在預測期內鎮痛領域將是最大的。

預計鎮痛領域將佔最大佔有率。鎮痛藥是用於控制和治療疼痛的藥物。通常用於緩解輕度至中度疼痛的止痛藥包括常見的成藥，如對乙醯胺酚、Ibuprofen和阿斯匹靈。這些藥物可治療多種疼痛，包括頭痛、肌肉疼痛、月經疼痛和輕微關節疼痛。鎮痛藥細分市場的特點是易於取得、易於使用和消費者廣泛接受，對成藥市場的整體成長做出了重大貢獻。

預計錠劑產業在預測期內年複合成長率最高

預計錠劑市場在預測期內將出現良好成長。錠劑是固態壓縮藥物型態，含有活性成分和各種賦形劑。由於每錠劑含有標準化量的活性成分，因此錠劑可以精確控制劑量。這確保了劑量的一致性並幫助消費者遵守建議的使用指南。此外，錠劑具有多種治療作用，可以解決疼痛、過敏、消化器官系統問題和營養缺乏等問題。錠劑因其方便、劑量準確且可提供多種藥物而在成藥市場上廣泛使用和流行。

比最大的地區

由於醫療保健意識的提高、可支配收入的增加和人口的成長，亞太地區在預測期內佔據了最大的市場佔有率。忙碌的生活方式、容易取得的資訊以及對非處方箋藥的偏好等因素正在推動自我治療的趨勢。此外，由於文化差異、醫療保健實踐和歷史因素，各國的偏好和購買行為也有所不同。了解這些細微差別對於希望在該地區建立強大影響力的公司至關重要。

年複合成長率最高的地區：

預計北美在預測期內將實現盈利成長。北美消費者通常更喜歡自我護理和非處方解決方案來解決常見的健康問題。這一趨勢是由便利性、可用性以及無需處方箋即可治療小病的願望等因素所推動的。北美的法規環境明確，美國食品藥物管理局(FDA) 和加拿大衛生署監督監督成藥的核准和監管。此外，北美OTC市場競爭激烈，國內外藥企競相爭取市場佔有率。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球成藥市場：依產品

  • 止痛藥
  • 消化和腸道療法
  • 感冒和咳嗽的補救措施
  • 維生素和礦物質
  • 皮膚科產品
  • 其他產品

第6章全球成藥市場：按劑型

  • 錠劑
  • 軟膏
  • 液體
  • 噴
  • 其他劑型

第7章 全球成藥市場：依給藥途徑分類

  • 口服
  • 胃腸外的
  • 外用
  • 其他給藥途徑

第8章全球成藥市場：依分銷管道分類

  • 藥局和零售藥局
  • 網路藥房
  • 醫院藥房

第9章 全球成藥市場：依最終用戶分類

  • 專科診所
  • 醫院
  • 居家照護
  • 其他最終用戶

第10章 全球成藥市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Bayer AG
  • Pfizer
  • Takeda Pharmaceutical Company Ltd.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Sanofi SA
  • GlaxoSmithKline PLC
  • Reckitt Benckiser Group PLC
  • Boehringer Ingelheim International GmbH
  • Mylan
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd
  • Cipla, Inc
  • Glenmark Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories
  • Alkem Laboratories Limited
  • Viatris, Inc
  • The Blackstone Group, Inc.
  • Aytu Biopharma, Inc.
  • Merck & Co. Inc.
Product Code: SMRC25199

According to Stratistics MRC, the Global Over the Counter Drug Market is accounted for $173.34 billion in 2023 and is expected to reach $278.34 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Over-the-Counter (OTC) drugs refer to medications that are available for purchase without a prescription from a healthcare professional. These drugs play a crucial role in providing accessible and convenient solutions for consumers to address minor health issues like common cold, body pain, allergies and flu, heartburn, acne, and other basic health problems. Acetaminophen, aspirin, antacids, decongestants, antihistamines, and laxatives are the examples of OTC drugs. These drugs are chosen by regulatory agencies in many countries to guarantee that they contain chemicals that are safe and effective when taken without the supervision of a physician.

According to a National Institute of Health report, 93% of adults in the U.S. prefer to treat minor illnesses with over the counter drugs before seeking professional help, and 85% of parents prefer to treat minor illnesses in their children with over the counter drugs before seeking professional help.

Market Dynamics:

Driver:

Growing demand for self-medications

Self-medication becomes increasingly popular as people explore readily accessible remedies without a prescription. These medications are readily available in pharmacies, supermarkets, convenience stores, and increasingly through online platforms. This accessibility allows consumers to easily purchase medications for minor ailments and everyday health concerns. Moreover, affordability is a key advantage of OTC drugs compared to prescription medications. With a focus on affordability and ease of access, the market benefits from consumers' preference for managing minor health issues on their own, contributing to the overall growth of the OTC Drug Market.

Restraint:

Safety concerns

OTC drugs, available without a prescription, pose risks of misuse, abuse, and adverse effects due to self-administration by consumers. As individuals may lack professional medical guidance, there's an increased potential for incorrect dosage, drug interactions, or reliance on OTC options for conditions requiring professional intervention. This raises regulatory scrutiny to ensure consumer safety. Instances of adverse reactions or safety issues may result in product recalls or restrictions, impacting market dynamics.

Opportunity:

Global aging population

As the world's population ages, there is a concurrent increase in the prevalence of age-related health issues and chronic conditions. OTC drugs cater to the rising demand for self-medication among the elderly, offering accessible and cost-effective solutions for common ailments. Moreover, aging is often associated with various health concerns, such as joint pain, arthritis, cardiovascular issues, and digestive problems. OTC drugs provide a convenient solution for managing these common ailments without the need for a prescription. OTC products, including vitamins, supplements, and wellness-focused medications, align with the trend of maintaining overall health and preventing age-related issues.

Threat:

Competition from generic drugs

The introduction of generic substitutes, which are frequently less expensive than branded over-the-counter medications, increases market rivalry and put well-known companies under pressure. Generic options, while meeting regulatory standards, can erode profit margins and diminish the market share of branded OTC drugs. Also, the branded OTC drugs may lose their exclusivity as generic options become available, leading to a reduction in market exclusivity and potentially impacting the sales and revenue of the original products.

Covid-19 Impact

Increased health awareness, preventive measures, and heightened demand for self-care products during the pandemic led to a surge in OTC sales. Consumers sought remedies for common symptoms, boosting sales of immune boosters, cough and cold medications, and hygiene-related products. However, disruptions in the supply chain, changes in consumer spending patterns, and economic uncertainties also presented challenges. The pandemic underscored the importance of adaptability and innovation in the OTC industry, shaping new trends in consumer behaviour and market dynamics.

The analgesics segment is expected to be the largest during the forecast period

The analgesics segment is estimated to hold the largest share. Analgesics are medications used in the management and treatment of pain. Widely used to alleviate mild to moderate pain, analgesics include common OTC drugs such as acetaminophen, ibuprofen, and aspirin. These medications addresses a broad spectrum of pain conditions, including headaches, muscle pain, menstrual cramps, and minor arthritis pain. The analgesics segment is characterized by its accessibility ease of use, and broad consumer acceptance, contributing significantly to the overall OTC drug market's growth

The tablets segment is expected to have the highest CAGR during the forecast period

The tablets segment is anticipated to have lucrative growth during the forecast period. Tablets are solid, compressed forms of medication, containing active ingredients along with various excipients. Tablets offer precise dosage control, with each tablet containing a standardized amount of the active ingredient. This ensures consistency in dosing and helps consumers follow recommended usage guidelines. Moreover, they cater to various therapeutic areas, addressing conditions like pain, allergies, digestive issues, and nutritional deficiencies. The convenience, precision in dosing, and broad range of medications available in tablet form contribute to their widespread use and popularity in the OTC drug market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing healthcare awareness, rising disposable incomes, and a growing population. There's a notable trend towards self-medication, driven by factors such as busy lifestyles, easy access to information, and a preference for non-prescription solutions. Moreover, preferences and buying behaviours vary across countries due to cultural differences, healthcare practices, and historical factors. Understanding these nuances is essential for companies aiming to establish a strong presence in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period. Consumers in North America often prefer self-care and over-the-counter solutions for common health issues. This trend is driven by factors like convenience, accessibility, and the desire to manage minor ailments without the need for a prescription. The regulatory environment in North America is well-defined, with the U.S. Food and Drug Administration (FDA) and Health Canada overseeing the approval and regulation of OTC drugs. Furthermore, the North American OTC market is highly competitive, with both domestic and multinational pharmaceutical companies vying for market share.

Key players in the market

Some of the key players in the Over the Counter Drug Market include Bayer AG, Pfizer, Takeda Pharmaceutical Company Ltd., Johnson & Johnson Services Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Boehringer Ingelheim International GmbH, Mylan, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Cipla Inc., Glenmark Pharmaceuticals Ltd, Dr. Reddy's Laboratories, Alkem Laboratories Limited, Viatris, Inc, The Blackstone Group, Inc., Aytu Biopharma, Inc. and Merck & Co. Inc.

Key Developments:

In June 2022, Glenmark Pharmaceuticals Ltd. acquired a portfolio of approved OTC abbreviated new drug applications (ANDAs) in the U.S. from Wockhardt. The acquired ANDAs helped the company expand its OTC portfolio in the U.S.

In June 2021, Bayer announced the approval of Astepro Allergyfrom the U.S. Food and Drug (FDA) as an over the counter (OTC) product for the temporary relief of nasal congestion runny nose and Itchy nose and other respiratory allergies.

Products Covered:

  • Analgesics
  • Digestives & Intestinal Remedies
  • Cold & Cough Remedies
  • Vitamins & Minerals
  • Dermatological Products
  • Other Products

Dosage Forms Covered:

  • Tablets
  • Ointments
  • Liquids
  • Sprays
  • Other Dosage Forms

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Topical
  • Other Routes of Administration

Distribution Channels Covered:

  • Drug Stores & Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

End Users Covered:

  • Speciality Clinic
  • Hospital
  • Homecare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Over the Counter Drug Market, By Product

  • 5.1 Introduction
  • 5.2 Analgesics
  • 5.3 Digestives & Intestinal Remedies
  • 5.4 Cold & Cough Remedies
  • 5.5 Vitamins & Minerals
  • 5.6 Dermatological Products
  • 5.7 Other Products

6 Global Over the Counter Drug Market, By Dosage Form

  • 6.1 Introduction
  • 6.2 Tablets
  • 6.3 Ointments
  • 6.4 Liquids
  • 6.5 Sprays
  • 6.6 Other Dosage Forms

7 Global Over the Counter Drug Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Parenteral
  • 7.4 Topical
  • 7.5 Other Routes of Administration

8 Global Over the Counter Drug Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Drug Stores & Retail Pharmacies
  • 8.3 Online Pharmacies
  • 8.4 Hospital Pharmacies

9 Global Over the Counter Drug Market, By End User

  • 9.1 Introduction
  • 9.2 Speciality Clinic
  • 9.3 Hospital
  • 9.4 Homecare
  • 9.5 Other End Users

10 Global Over the Counter Drug Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Bayer AG
  • 12.2 Pfizer
  • 12.3 Takeda Pharmaceutical Company Ltd.
  • 12.4 Johnson & Johnson Services Inc.
  • 12.5 Novartis AG
  • 12.6 Sanofi S.A.
  • 12.7 GlaxoSmithKline PLC
  • 12.8 Reckitt Benckiser Group PLC
  • 12.9 Boehringer Ingelheim International GmbH
  • 12.10 Mylan
  • 12.11 Sun Pharmaceutical Industries Ltd
  • 12.12 Teva Pharmaceutical Industries Ltd
  • 12.13 Cipla, Inc
  • 12.14 Glenmark Pharmaceuticals Ltd
  • 12.15 Dr. Reddy's Laboratories
  • 12.16 Alkem Laboratories Limited
  • 12.17 Viatris, Inc
  • 12.18 The Blackstone Group, Inc.
  • 12.19 Aytu Biopharma, Inc.
  • 12.20 Merck & Co. Inc.

List of Tables

  • Table 1 Global Over the Counter Drug Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Over the Counter Drug Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Over the Counter Drug Market Outlook, By Analgesics (2021-2030) ($MN)
  • Table 4 Global Over the Counter Drug Market Outlook, By Digestives & Intestinal Remedies (2021-2030) ($MN)
  • Table 5 Global Over the Counter Drug Market Outlook, By Cold & Cough Remedies (2021-2030) ($MN)
  • Table 6 Global Over the Counter Drug Market Outlook, By Vitamins & Minerals (2021-2030) ($MN)
  • Table 7 Global Over the Counter Drug Market Outlook, By Dermatological Products (2021-2030) ($MN)
  • Table 8 Global Over the Counter Drug Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Over the Counter Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
  • Table 10 Global Over the Counter Drug Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 11 Global Over the Counter Drug Market Outlook, By Ointments (2021-2030) ($MN)
  • Table 12 Global Over the Counter Drug Market Outlook, By Liquids (2021-2030) ($MN)
  • Table 13 Global Over the Counter Drug Market Outlook, By Sprays (2021-2030) ($MN)
  • Table 14 Global Over the Counter Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
  • Table 15 Global Over the Counter Drug Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 16 Global Over the Counter Drug Market Outlook, By Oral (2021-2030) ($MN)
  • Table 17 Global Over the Counter Drug Market Outlook, By Parenteral (2021-2030) ($MN)
  • Table 18 Global Over the Counter Drug Market Outlook, By Topical (2021-2030) ($MN)
  • Table 19 Global Over the Counter Drug Market Outlook, By Other Routes of Administration (2021-2030) ($MN)
  • Table 20 Global Over the Counter Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 21 Global Over the Counter Drug Market Outlook, By Drug Stores & Retail Pharmacies (2021-2030) ($MN)
  • Table 22 Global Over the Counter Drug Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 23 Global Over the Counter Drug Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 24 Global Over the Counter Drug Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 Global Over the Counter Drug Market Outlook, By Speciality Clinic (2021-2030) ($MN)
  • Table 26 Global Over the Counter Drug Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 27 Global Over the Counter Drug Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 28 Global Over the Counter Drug Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.